EHA- lidocaine hydrochloride lotion 
Asclemed USA, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

Active Ingredients

Lidocaine HCI 4%

Purpose

External Anesthetic

Uses

For temporary relief of pain and itching and minor skin irritations due to minor cuts and scrapes, sunburns, and minor burns.

Warning

For external use only.

Avoid contact with eyes

Stop using this product and ask doctor if

  • symptoms last for more than seven days, or clear up and occur again within a few days
  • if redness, irritation, swelling, pain or other symptoms increase

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For adults and children two-years or older, apply externally to the affected area. Do not use more than three to four times per day.

Inactive ingredients

Inactive ingredients: Aqua (Deionized Water), C13-14 Isoparaffin, Glyceryl Stearate, Helianthus Annuus (Sunflower) Seed Oil, Isopropyl Myristate, Laureth-7, M Polyacrylamide, Steric Acid.

Principal Display Panel - 88 mL Bottle Label

‘Eha Lotion 4%

Pain Relief Lotion

For Professional Use Only

3 OZ (88 mL)

Distributed by

Enovachem ™

PHARMACEUTICALS

Torrance, CA 90501

(310) 320-0100

Principal Display Panel
EHA 
lidocaine hydrochloride lotion
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:76420-351
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
HELIANTHUS ANNUUS FLOWERING TOP (UNII: BKJ0J3D1BP)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
LAURETH-7 (UNII: Z95S6G8201)  
METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:76420-351-3088 mL in 1 BOTTLE; Type 0: Not a Combination Product06/07/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/07/2016
Labeler - Asclemed USA, Inc. (059888437)

Revised: 11/2018
Document Id: 7d77ecf6-5731-d43e-e053-2991aa0af0db
Set id: 09835640-55c3-4bfa-9ad3-15d37f06e871
Version: 2
Effective Time: 20181101
 
Asclemed USA, Inc.